How will Covid-19/Coronavirus Affect my Alternative Investment Portfolio? Part 35: October 24
ianippolito.substack.com
U.S. continues to stall out while fighting second wave of deaths; World round up: Europe in crisis, and the Belgian triple-shortage nightmare; State round up: third infection wave surges across uncomfortably large swaths of the U.S.; Why the third wave may be much more challenging than the second; Georgia economic update: a mixed bag of good and awful; Economy gets tiny but welcome reprieve on new unemployment; Financial cliff update: little progress made as the clock continues to tick; Previously immune apartment REITs squeezed by rising vacancies and declining rents; FDA inspectors flag Eli-Lilly plant that's producing experimental Covid-19 vaccine for "major failure of quality assurance"; AstraZeneca and Johnson & Johnson vaccine trials are back on; Update on my portfolio strategy.
How will Covid-19/Coronavirus Affect my Alternative Investment Portfolio? Part 35: October 24
How will Covid-19/Coronavirus Affect my…
How will Covid-19/Coronavirus Affect my Alternative Investment Portfolio? Part 35: October 24
U.S. continues to stall out while fighting second wave of deaths; World round up: Europe in crisis, and the Belgian triple-shortage nightmare; State round up: third infection wave surges across uncomfortably large swaths of the U.S.; Why the third wave may be much more challenging than the second; Georgia economic update: a mixed bag of good and awful; Economy gets tiny but welcome reprieve on new unemployment; Financial cliff update: little progress made as the clock continues to tick; Previously immune apartment REITs squeezed by rising vacancies and declining rents; FDA inspectors flag Eli-Lilly plant that's producing experimental Covid-19 vaccine for "major failure of quality assurance"; AstraZeneca and Johnson & Johnson vaccine trials are back on; Update on my portfolio strategy.